Menu

Home / For Visitors / 2023 Exhibitor's Press Release / HANCHORBIO ANNOUNCES TFDA IND APPROVAL FOR HCB101 TO TREAT SOLID AND HEMATOLOGICAL MALIGNANCIES

 

TOP